Literature DB >> 30628926

SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.

Elodie Laurent1,2, Hugues Begueret3, Benjamin Bonhomme1, Rémi Veillon4, Matthieu Thumerel5, Valérie Velasco1, Véronique Brouste6, Stéphanie Hoppe6, Marion Fournier7, Thomas Grellety2,8,9, Gaëtan MacGrogan1,9.   

Abstract

Triple-negative breast cancer (TNBC) patients have an increased risk of developing visceral metastases and other primary nonbreast cancers, particularly lung cancer. The differential diagnosis of TNBC metastases and primary cancers from other organs can be difficult due to lack of a TNBC standard immunoprofile. We analyzed the diagnostic value of estrogen receptor, progesterone receptor, human epidermal growth factor receptor, thyroid transcription factor-1 (TTF1), Napsin A, mammaglobin, gross cystic disease fluid protein 15 (GCDFP15), Sry-related HMg-Box gene 10 (SOX10), GATA-binding protein 3 (GATA3), and androgen receptor in a series of 207 TNBC and 152 primary lung adenocarcinomas (LA). All tested TNBCs were TTF1 and Napsin A-negative. When comparing TNBC and TTF1-positive or negative LA, SOX10 had the best sensitivity (62.3%) and specificity (100%) as a marker in favor of TNBC compared with LA, irrespective of TTF1 status (P<0.0001). GATA3 had moderate sensitivity (30.4%) and excellent specificity (98.7%) and misclassified only 2/152 LA (1.3%). GCDFP15 had a moderate sensitivity (20.8%) and excellent specificity (98%) and misclassified only 3/152 (2%) LA. Mammaglobin and androgen receptor had moderate sensitivities (38.2% and 30%), good specificities (81.6% and 86%), and misclassified 28/152 and 21/152 LAs, respectively. In multivariate analysis, the best markers, enabling the distinction between SOX10-negative TNBC and TTF1 and Napsin A-negative LA were GATA3 (odds ratio=33.5; 95% confidence interval, 7.3-153.5; P<0.0001) and GCDFP15 (odds ratio=31.7; 95% confidence interval, 6.9-145.6; P<0.0001). Only 13/207 (6.3%) TNBC cases did not express any aforementioned marker. On the basis of our results, the best sequential immunohistochemical analysis to differentiate TNBC from TTF1-negative LA is first SOX10 followed by GATA3, and finally GCDFP15. This order is important in the diagnostic workup of small biopsies from lung nodules in women with a previous history of TNBC.

Entities:  

Year:  2019        PMID: 30628926     DOI: 10.1097/PAS.0000000000001216

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

1.  Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations.

Authors:  Julie Massé; Caroline Truntzer; Romain Boidot; Emmanuel Khalifa; Gaëlle Pérot; Valérie Velasco; Laétitia Mayeur; Claire Billerey-Larmonier; Larry Blanchard; Hélène Charitansky; Isabelle Soubeyran; Richard Iggo; Laurent Arnould; Gaëtan MacGrogan
Journal:  Mod Pathol       Date:  2019-12-19       Impact factor: 7.842

Review 2.  Pleural mesothelioma classification update.

Authors:  Mary Beth Beasley; Francoise Galateau-Salle; Sanja Dacic
Journal:  Virchows Arch       Date:  2021-01-21       Impact factor: 4.064

Review 3.  Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.

Authors:  Gaurav A Mehta; Pooja Khanna; Michael L Gatza
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-09       Impact factor: 2.673

Review 4.  Immunocytochemistry of effusions: Processing and commonly used immunomarkers.

Authors:  Vinod B Shidham; Beata Janikowski
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

5.  Clinical outcomes and prognostic biomarkers among pregnant, post-partum and nulliparous women with breast cancer: a prospective cohort study.

Authors:  Katarzyna J Jerzak; Nechama Lipton; Sharon Nofech-Mozes; Dina Boles; Elzbieta Slodkowska; Gregory R Pond; Ellen Warner
Journal:  Breast Cancer Res Treat       Date:  2021-07-27       Impact factor: 4.872

Review 6.  Sex-Determining Region Y Chromosome-Related High-Mobility-Group Box 10 in Cancer: A Potential Therapeutic Target.

Authors:  Liming Yu; Fan Peng; Xue Dong; Ying Chen; Dongdong Sun; Shuai Jiang; Chao Deng
Journal:  Front Cell Dev Biol       Date:  2020-12-03

Review 7.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

8.  Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.

Authors:  Lei Wang; Guan-Tian Lang; Meng-Zhu Xue; Liu Yang; Li Chen; Ling Yao; Xiao-Guang Li; Peng Wang; Xin Hu; Zhi-Ming Shao
Journal:  Theranostics       Date:  2020-08-21       Impact factor: 11.556

9.  Immunohistological Expression of SOX-10 in Triple-Negative Breast Cancer: A Descriptive Analysis of 113 Samples.

Authors:  Katharina Kriegsmann; Christa Flechtenmacher; Jörg Heil; Jörg Kriegsmann; Gunhild Mechtersheimer; Sebastian Aulmann; Wilko Weichert; Hans-Peter Sinn; Mark Kriegsmann
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923

10.  Correlation between Androgen Receptor Expression and Immunohistochemistry Type as Prognostic Factors in a Cohort of Breast Cancer Patients: Result from a Single-Center, Cross Sectional Study.

Authors:  Irina Niță; Cornelia Nițipir; Ștefania Andreea Toma; Alexandra Maria Limbău; Edvina Pîrvu; Ioana Anca Bădărău; Ioana Suciu; George Suciu; Loredana Sabina Cornelia Manolescu
Journal:  Healthcare (Basel)       Date:  2021-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.